July 25, 2017 7:58 AM ET

Healthcare Equipment and Supplies

Company Overview of IMCOR Pharmaceutical Co.

Company Overview

IMCOR Pharmaceutical Co. does not have significant operations. It owns Imagent, an ultrasound imaging contrast agent for use in patients with suboptimal echocardiograms. Prior to April 2005, the company engaged in the development and marketing of medical imaging pharmaceutical products. IMCOR was founded in 1994 as MT Financial Group, Inc. and changed its name to Photogen Technologies, Inc. in 1997. Later, it changed its name to IMCOR Pharmaceutical Co. in 2004. The company is headquartered in San Diego, California.

4660 La Jolla Drive

Suite 500

San Diego, CA 92122

United States

Founded in 1994





Key Executives for IMCOR Pharmaceutical Co.

Chairman and Acting Principal Financial Officer
Age: 68
Compensation as of Fiscal Year 2017.

Similar Private Companies By Industry

Company Name Region
.decimal, Inc. United States
20/20 GeneSystems, Inc. United States
20/20 Imaging LLC United States
21st Century Scientific, Inc. United States
21X Corporation United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
The Advertising Council, Inc. United States
Rush University United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact IMCOR Pharmaceutical Co., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.